| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |